iPLATO has been granted NHS Digital assurance for its patient facing app, myGP®, for all practices using SystmOne. The app, which is currently available to all patients registered at an
MoreToday, an independent review of adult screening programmes in England, was published. Commissioned by the NHS the review came after a self-admitted difficult period for the NHS. His review addresses all
MoreMeasles is a potentially life-threatening disease. Until recently a hugely successful NHS vaccination programme meant that measles had become a disease of the past in the UK. Now it is
MoreKalpik Singh, Test Analyst, discusses why iPLATO has chosen to switch to microservices. APIs are essential in our day-to-day work - an API is a set of definitions and protocols
MoreData published in The Lancet, The BMJ and most recently National Institute of Health Research has confirmed that using SMS reminders for screening, clinic attendance and health checks has dramatically
MoreiPLATO has been ranked number 77 in The Sunday Times Hiscox Tech Track 100. The league table ranks Britain’s top 100 private tech companies with the fastest-growing sales over the
MoreWe are delighted to announce that we have been shortlisted at the FORWARD HEALTHCARE AWARDS for Driving Technology Forward with Patient Messaging - winners will be announced on 25th September
MoreWith over 1 million patients using myGP, we continue to simplify access to healthcare with a host of powerful features. We are really pleased to let you know that Medical Record Access
MoreiPLATO Healthcare has been awarded highly commended of the Innovation Award at the inaugural Cheshire and Merseyside Digit@LL Awards celebration, honouring innovative work and digital technology developments that have delivered
MoreWe are delighted to announce that iPLATO won a contract to help improve breast and cervical cancer screening attendance in Barnet, London. This project, available to 52 GP practices covering
More